Jabbour SA - Search Results

1

Physicians' Considerations and Practice Recommendations Regarding the Use of Sodium-Glucose Cotransporter-2 Inhibitors.

Jabbour SA, Ibrahim NE, Argyropoulos CP. Jabbour SA, et al. J Clin Med. 2022 Oct 13;11(20):6051. doi: 10.3390/jcm11206051. J Clin Med. 2022. PMID: 36294370 Free PMC article. Review.

2

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.

Jabbour SA, Goldstein BJ. Jabbour SA, et al. Int J Clin Pract. 2008 Aug;62(8):1279-84. doi: 10.1111/j.1742-1241.2008.01829.x. Int J Clin Pract. 2008. PMID: 18705823 Review.

3

SGLT2 inhibitors.

Dardi I, Kouvatsos T, Jabbour SA. Dardi I, et al. Among authors: jabbour sa. Biochem Pharmacol. 2016 Feb 1;101:27-39. doi: 10.1016/j.bcp.2015.09.005. Epub 2015 Sep 8. Biochem Pharmacol. 2016. PMID: 26362302

4

Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice.

Khunti K, Jabbour S, Cos X, Mudaliar S, Mende C, Bonaca M, Fioretto P. Khunti K, et al. Diabetes Obes Metab. 2022 Jul;24(7):1187-1196. doi: 10.1111/dom.14684. Epub 2022 Mar 30. Diabetes Obes Metab. 2022. PMID: 35238129 Free PMC article. Review.

5

Diabetes knowledge: are resident physicians and nurses adequately prepared to manage diabetes?

Rubin DJ, Moshang J, Jabbour SA. Rubin DJ, et al. Among authors: jabbour sa. Endocr Pract. 2007 Jan-Feb;13(1):17-21. doi: 10.4158/EP.13.1.17. Endocr Pract. 2007. PMID: 17360296

6

Hypoglycemia in hospitalized patients treated with antihyperglycemic agents.

Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE. Varghese P, et al. J Hosp Med. 2007 Jul;2(4):234-40. doi: 10.1002/jhm.212. J Hosp Med. 2007. PMID: 17702035

7

Endocrine incidentalomas.

Shirodkar M, Jabbour SA. Shirodkar M, et al. Among authors: jabbour sa. Int J Clin Pract. 2008 Sep;62(9):1423-31. doi: 10.1111/j.1742-1241.2008.01831.x. Epub 2008 Jul 24. Int J Clin Pract. 2008. PMID: 18657198 Review.

8

Subclinical hyperthyroidism: current concepts and scintigraphic imaging.

Intenzo C, Jabbour S, Miller JL, Ahmed I, Furlong K, Kushen M, Kim SM, Capuzzi DM. Intenzo C, et al. Clin Nucl Med. 2011 Sep;36(9):e107-13. doi: 10.1097/RLU.0b013e3182175477. Clin Nucl Med. 2011. PMID: 21825836 Review.

9

Durability of response to dapagliflozin: a review of long-term efficacy and safety.

Jabbour S. Jabbour S. Curr Med Res Opin. 2017 Sep;33(9):1685-1696. doi: 10.1080/03007995.2017.1354822. Epub 2017 Jul 31. Curr Med Res Opin. 2017. PMID: 28699798 Review.

10

Continuous Glucose Monitoring Profiles and Health Outcomes after Dapagliflozin Plus Saxagliptin vs Insulin Glargine.

Simonson DC, Testa MA, Ekholm E, Su M, Vilsbøll T, Jabbour SA, Lind M. Simonson DC, et al. Among authors: jabbour sa. J Clin Endocrinol Metab. 2024 Feb 27:dgae105. doi: 10.1210/clinem/dgae105. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38412282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page